Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 93
Filter
1.
Clin Exp Immunol ; 156(3): 535-41, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19438608

ABSTRACT

The two clinical phenotypes of gluten enteropathy, coeliac disease (CD) and dermatitis herpetiformis (DH), were characterized for numbers and homing profiles of circulating final effector B cells, plasmablasts, identified as immunoglobulin (Ig)-secreting cells (ISC). In CD, the numbers of ISC were approximately 50% lower than in DH or controls. ISC expressed peripheral lymph node homing receptor (HR), L-selectin, less frequently in CD (54%) and DH (52%) patients than in controls (70%). The expression of gut mucosal HR, alpha(4)beta(7), was less frequent in CD (42%) than in DH (65%) or controls (60%). In DH, but not in CD or controls, a higher proportion of IgA1-ISC (40%) than IgA2-ISC (25%) expressed the skin HR, cutaneous lymphocyte-associated antigen. In gluten enteropathy circulating plasmablasts are more mature, but decreased in number, and have distorted homing profiles. Differential IgA1-plasmablast homing could be associated with the development of skin rash with IgA1-deposits in DH but not in CD.


Subject(s)
Celiac Disease/immunology , Dermatitis Herpetiformis/immunology , Immunoglobulin A/analysis , Plasma Cells/immunology , Skin/immunology , Adult , Cell Differentiation/immunology , Female , Humans , Immunity, Mucosal , Immunoglobulin A/biosynthesis , Immunoglobulin G/biosynthesis , Immunoglobulin M/biosynthesis , Intestinal Mucosa/immunology , Male , Middle Aged , Receptors, Lymphocyte Homing/metabolism , Young Adult
2.
Appl Environ Microbiol ; 70(2): 670-4, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14766540

ABSTRACT

Long residence times of probiotics in the intestinal tract would prolong their potential beneficial health effects and assist colonization. This study investigated the colonization potential of Lactobacillus casei Shirota in mouse intestine by using 5 (and 6)-carboxyfluorescein diacetate, succinimidyl ester (cFDA-SE) for assessment of doubling times in different parts of the intestine. The amounts of intestinal water overlying the surfaces of the duodenum, jejunum, ileum, and colon in BALB/c mice were 34.4 +/- 2.9, 58.8 +/- 6.8, 21.6 +/- 2.2, and 8.0 +/- 1.0 mg, respectively. Based on the residual concentrations of cFDA-SE-labeled lactobacilli on intestinal mucosal surfaces, the average half times for the wash-out of lactobacilli fed were estimated at 3.98, 1.55, 1.34, and 2.48 days in the duodenum, jejunum, ileum, and colon, respectively. The average doubling times of the lactobacilli, estimated from the residual fluorescent levels of surface-adhered cells, were 4.10, 4.78, 4.56, and 5.59 days in the duodenum, jejunum, ileum, and colon, respectively. It is estimated that the lactobacilli would have to achieve an average doubling time of 1.03 to 2.04 days to colonize the various sections of the mouse intestinal tract more permanently.


Subject(s)
Intestines/microbiology , Lacticaseibacillus casei/growth & development , Probiotics , Animals , Cell Division , Culture Media , Female , Fluoresceins , Fluorescent Dyes , Humans , Mice , Mice, Inbred BALB C , Models, Animal
3.
Rheumatology (Oxford) ; 41(6): 651-7, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12048291

ABSTRACT

OBJECTIVE: To investigate the influence of the major histocompatibility complex (MHC) class I molecule HLA-B27 on (i) the invasion of Salmonella and Yersinia into human intestinal epithelial cells, (ii) the survival of intracellular Salmonella in these cells, and (iii) the production of certain inflammatory cytokines by the cells after Salmonella infection. METHODS: The human intestinal epithelial cell line Henle-407 was transfected with HLA-B27 DNA. These cells and HLA-B27-negative control cells were infected with Salmonella or Yersinia, and viable intracellular bacteria were determined as colony-forming units. Cytokine production was assayed with ELISA. RESULTS: Salmonella invaded HLA-B27-positive Henle cells in higher numbers than HLA-B27-negative control cells. However, HLA-B27 did not affect the invasion of Yersinia or the survival of the intracellular bacteria in these intestinal epithelial cells. Salmonella infection induced production of interleukin-8 (IL-8), IL-6 and monocyte chemotactic protein 1 (MCP-1) by Henle cells that was not affected by HLA-B27 in a specific way. CONCLUSIONS: These findings suggest that HLA-B27 enhances the invasion of Salmonella into intestinal epithelial cells. The interaction between bacteria and intestinal epithelial cells plays an important role during the early phases of ReA. HLA-B27-linked modulation of Salmonella invasion may lead to an increased load of Salmonella in intestinal tissue and thus increased susceptibility to reactive arthritis.


Subject(s)
Epithelial Cells/microbiology , HLA-B27 Antigen/immunology , Intestinal Mucosa/cytology , Salmonella Infections/immunology , Salmonella enteritidis/pathogenicity , Cells, Cultured , Cytokines/immunology , Epithelial Cells/cytology , Epithelial Cells/immunology , Gene Expression/immunology , HLA-B27 Antigen/genetics , Humans , Intestinal Mucosa/immunology , Prohibitins , Salmonella Infections/microbiology , Salmonella Infections/pathology , Salmonella enteritidis/immunology , Transfection , Virulence
4.
Emerg Infect Dis ; 7(6): 952-8, 2001.
Article in English | MEDLINE | ID: mdl-11747721

ABSTRACT

Recently, eight allelic variants of the pertactin gene (prn1-8) have been characterized in Bordetella pertussis strains isolated in Europe and the United States. It has been suggested that the divergence of the pertactin types of clinical isolates from those of the B. pertussis vaccine strains is a result of vaccine-driven evolution. Sequencing of the prn, which is relatively time-consuming, has so far been the only method for the differentiation of prn types. We have developed a rapid real-time polymerase chain reaction assay suitable for large-scale screening of the prn type of the circulating strains. This method correctly identified the prn type of all tested 41 clinical isolates and two Finnish vaccine strains. The method is simple and reliable and provides an alternative for sequencing in pertussis research.


Subject(s)
Bacterial Outer Membrane Proteins/genetics , Bordetella pertussis/genetics , Genes, Bacterial , Genetic Variation , Virulence Factors, Bordetella , Amino Acid Sequence , Base Sequence , Bordetella pertussis/isolation & purification , DNA Probes , DNA, Bacterial , Electrophoresis, Agar Gel/methods , Humans , Molecular Sequence Data , Pertussis Vaccine/genetics , Polymerase Chain Reaction/methods , Time Factors
5.
FEMS Immunol Med Microbiol ; 31(2): 93-6, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11549415

ABSTRACT

Eighteen healthy volunteers were randomized into two treatment groups and consumed liquid prepackaged bovine colostrum whey and placebo for 7 days. On days 1, 3 and 5, an attenuated Salmonella typhi Ty21a oral vaccine was given to all subjects to mimic an enteropathogenic infection. The circulating antibody secreting cells and the expression of phagocytosis receptors of the subjects before and after oral immunization were measured with the ELISPOT assay and flow cytometry. All subjects responded well to the vaccine. No significant differences were observed in ELISPOT values for IgA, IgG, IgM, Fcgamma and CR receptor expression on neutrophils and monocytes between the two groups. There was a trend towards greater increase in specific IgA among the subjects receiving their vaccine with bovine colostrum. These results suggest that bovine colostrum may possess some potential to enhance human special immune responses.


Subject(s)
Antibodies, Bacterial/immunology , Colostrum/immunology , Immunoglobulins/immunology , Salmonella Vaccines/immunology , Salmonella typhi/immunology , Administration, Oral , Adult , Animals , Antibodies, Bacterial/biosynthesis , Cattle , Female , Humans , Immunoglobulins/biosynthesis , Male , Middle Aged , Milk Proteins/immunology , Receptors, Complement/metabolism , Receptors, IgG/metabolism , Salmonella Vaccines/administration & dosage , Vaccination , Whey Proteins
7.
Lancet ; 357(9262): 1076-9, 2001 Apr 07.
Article in English | MEDLINE | ID: mdl-11297958

ABSTRACT

BACKGROUND: Reversal of the progressive increase in frequency of atopic disease would be an important breakthrough for health care and wellbeing in western societies. In the hygiene hypothesis this increase is attributed to reduced microbial exposure in early life. Probiotics are cultures of potentially beneficial bacteria of the healthy gut microflora. We assessed the effect on atopic disease of Lactobacillus GG (which is safe at an early age and effective in treatment of allergic inflammation and food allergy). METHODS: In a double-blind, randomised placebo-controlled trial we gave Lactobacillus GG prenatally to mothers who had at least one first-degree relative (or partner) with atopic eczema, allergic rhinitis, or asthma, and postnatally for 6 months to their infants. Chronic recurring atopic eczema, which is the main sign of atopic disease in the first years of life, was the primary endpoint. FINDINGS: Atopic eczema was diagnosed in 46 of 132 (35%) children aged 2 years. Asthma was diagnosed in six of these children and allergic rhinitis in one. The frequency of atopic eczema in the probiotic group was half that of the placebo group (15/64 [23%] vs 31/68 [46%]; relative risk 0.51 [95% CI 0.32-0.84]). The number needed to treat was 4.5 (95% CI 2.6-15.6). INTERPRETATIONS: Lactobacillus GG was effective in prevention of early atopic disease in children at high risk. Thus, gut microflora might be a hitherto unexplored source of natural immunomodulators and probiotics, for prevention of atopic disease.


Subject(s)
Hypersensitivity, Immediate/prevention & control , Lactobacillus , Probiotics/therapeutic use , Child, Preschool , Chronic Disease , Dermatitis, Atopic/genetics , Dermatitis, Atopic/immunology , Dermatitis, Atopic/prevention & control , Double-Blind Method , Female , Humans , Hypersensitivity, Immediate/diagnosis , Hypersensitivity, Immediate/genetics , Immunoglobulin E/blood , Infant , Infant, Newborn , Intestines/microbiology , Pregnancy , Prenatal Exposure Delayed Effects , Primary Prevention , Probiotics/administration & dosage , Recurrence , Risk Factors , Skin Tests
8.
Am J Clin Nutr ; 73(2 Suppl): 444S-450S, 2001 02.
Article in English | MEDLINE | ID: mdl-11157355

ABSTRACT

The gastrointestinal tract functions as a barrier against antigens from microorganisms and food. The generation of immunophysiologic regulation in the gut depends on the establishment of indigenous microflora. This has led to the introduction of novel therapeutic interventions based on the consumption of cultures of beneficial live microorganisms that act as probiotics. Among the possible mechanisms of probiotic therapy is promotion of a nonimmunologic gut defense barrier, which includes the normalization of increased intestinal permeability and altered gut microecology. Another possible mechanism of probiotic therapy is improvement of the intestine's immunologic barrier, particularly through intestinal immunoglobulin A responses and alleviation of intestinal inflammatory responses, which produce a gut-stabilizing effect. Many probiotic effects are mediated through immune regulation, particularly through balance control of proinflammatory and anti-inflammatory cytokines. These data show that probiotics can be used as innovative tools to alleviate intestinal inflammation, normalize gut mucosal dysfunction, and down-regulate hypersensitivity reactions. More recent data show that differences exist in the immunomodulatory effects of candidate probiotic bacteria. Moreover, distinct regulatory effects have been detected in healthy subjects and in patients with inflammatory diseases. These results suggest that specific immunomodulatory properties of probiotic bacteria should be characterized when developing clinical applications for extended target populations.


Subject(s)
Digestive System/immunology , Immune System/immunology , Intestines/immunology , Probiotics/pharmacology , Adjuvants, Immunologic/pharmacology , Antigens/physiology , Cytokines , Digestive System/microbiology , Humans , Hypersensitivity , Immune System/microbiology , Immunity, Mucosal , Immunoglobulin A/immunology , Inflammation/therapy , Intestines/microbiology , Lymphocytes , Permeability
9.
Arch Dis Child Fetal Neonatal Ed ; 83(3): F186-92, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11040166

ABSTRACT

AIM: To evaluate the role of intestinal microflora and early formula feeding in the maturation of humoral immunity in healthy newborn infants. STUDY DESIGN: Sixty four healthy infants were studied. Faecal colonisation with Bacteroides fragilis group, Bifidobacterium-like, and Lactobacillus-like bacteria was examined at 1, 2, and 6 months of age, and also the number of IgA-secreting, IgM-secreting, and IgG-secreting cells (detected by ELISPOT) at 0, 2, and 6 months of age. RESULTS: Intestinal colonisation with bacteria from the B fragilis group was more closely associated with maturation of IgA-secreting and IgM-secreting cells than colonisation with the other bacterial genera studied or diet. Infants colonised with B fragilis at 1 month of age had more IgA-secreting and IgM-secreting cells/10(6) mononuclear cells at 2 months of age (geometric mean (95% confidence interval) 1393 (962 to 2018) and 754 (427 to 1332) respectively) than infants not colonised (1015 (826 to 1247) and 394 (304 to 511) respectively); p = 0.04 and p = 0.009 respectively. CONCLUSIONS: The type of bacteria colonising the intestine of newborns and the timing may determine the immunomodulation of the naive immune system.


Subject(s)
Antibody Formation/physiology , Intestines/microbiology , Analysis of Variance , Anti-Bacterial Agents/therapeutic use , Bacteroides fragilis/isolation & purification , Bifidobacterium/isolation & purification , Clostridium perfringens/isolation & purification , Colony Count, Microbial , Delivery, Obstetric , Enzyme-Linked Immunosorbent Assay , Feces/microbiology , Humans , Immunoglobulin A/metabolism , Immunoglobulin G/metabolism , Immunoglobulin M/metabolism , Infant , Infant Food , Infant, Newborn , Intestines/immunology , Lactobacillus/isolation & purification , Medical Records
10.
Vaccine ; 18(19): 1971-4, 2000 Apr 03.
Article in English | MEDLINE | ID: mdl-10706957

ABSTRACT

Pertussis-specific antibody and cell-mediated immune (CMI) responses were studied in adults 8 years after booster immunization with either a bicomponent (pertussis toxin and filamentous hemagglutinin) or a monocomponent (pertactin) acellular vaccine and in age-matched healthy controls. The levels of vaccine-induced antibodies were also compared between the serum samples collected before, 1 month, 4 years, and 8 years after immunization. Over the follow-up period, geometric mean values (GMV) of antibodies to the vaccine antigens decreased in both groups of vaccinees. However, the 8-year postimmunization GMV were 3-20 times higher than preimmunization GMV (all P values <0.01). Moreover, both antibody and CMI responses to the vaccine antigens were significantly higher in the vaccinees than in the controls (all P<0.01 for antibody; all P<0.001 for CMI responses). The results show that antibody and CMI responses induced by acellular pertussis vaccines can persist for up to 8 years after booster immunization of adults primed with whole-cell vaccine.


Subject(s)
Antigens, Bacterial , Bordetella pertussis/immunology , Pertussis Vaccine/immunology , Adhesins, Bacterial/administration & dosage , Adhesins, Bacterial/immunology , Adult , Antibodies, Bacterial/blood , Bacterial Outer Membrane Proteins/administration & dosage , Bacterial Outer Membrane Proteins/immunology , Case-Control Studies , Female , Hemagglutinins/administration & dosage , Hemagglutinins/immunology , Humans , Immunity, Cellular , Immunization, Secondary , In Vitro Techniques , Lymphocyte Activation , Male , Pertussis Toxin , Pertussis Vaccine/administration & dosage , Time Factors , Virulence Factors, Bordetella/administration & dosage , Virulence Factors, Bordetella/immunology
12.
J Allergy Clin Immunol ; 104(6): 1251-7, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10589009

ABSTRACT

BACKGROUND: According to data from animal and in vitro studies, transforming growth factor-beta (TGF-beta) has a crucial effect on 2 essential parts of the mucosal immune system: IgA production and oral tolerance induction. OBJECTIVE: We sought to ascertain whether TGF-beta in breast milk is associated with specific IgA production and atopic disease in human subjects. METHODS: Forty-seven infants with several atopic family members were followed during their first year of life. The concentrations of TGF-beta1 and TGF-beta2 in maternal colostrum, mature milk, and the infants' sera were determined. The enzyme-linked immunospot assay was used to assess the infants' specific IgA production in response to beta-lactoglobulin, casein, gliadin, and ovalbumin. RESULTS: At 12 months, atopic dermatitis was confirmed in 29 of 47 infants; in 11, atopic disease had begun during exclusive breast-feeding (preweaning onset), whereas in 18 the disease manifested itself after weaning (postweaning onset). The concentrations of both TGF-beta1 and TGF-beta2 were higher in maternal colostrum, but not in mature milk and infants' serum, in infants with postweaning-onset atopic disease compared with those with preweaning-onset disease (P =.0008 and P =. 015, respectively). The concentration of TGF-beta2 was, and that of TGF-beta1 tended to be, higher in the colostrum of mothers whose infants had specific IgA-secreting cells at 3 months in response to at least one of the dietary antigens tested compared with those who did not have such cells (P =.048 and P =.076, respectively). CONCLUSION: TGF-beta in colostrum may prevent the development of atopic disease during exclusive breast-feeding and promote specific IgA production in human subjects.


Subject(s)
Hypersensitivity, Immediate/metabolism , Milk, Human/chemistry , Transforming Growth Factor beta/analysis , Animals , Antibody-Producing Cells/chemistry , Colostrum/chemistry , Enzyme-Linked Immunosorbent Assay/methods , Female , Humans , Infant , Infant, Newborn , Transforming Growth Factor beta/blood
13.
Pediatrics ; 104(6): e70, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10586004

ABSTRACT

OBJECTIVE: To evaluate the immunogenicity and reactogenicity of an acellular pertussis vaccine (pa) either formulated with diphtheria and tetanus toxoids (dTpa) or administered consecutively with a licensed tetanus and diphtheria vaccine (Td) as a 5th dose in adolescents. METHODS: A total of 510 healthy children 10 to 13 years of age were assigned randomly, using a single-blind design, to receive either the dTpa vaccine or the Td vaccine with the pa vaccine 1 month later. The quantities of 3 pertussis antigens (pertussis toxin, filamentous hemagglutinin, and pertactin) in the dTpa and the pa vaccines were one third of those of the Infanrix vaccine (SmithKline Beecham Biologicals, Rixensart, Beligium) licensed for use in infants. For enzyme-linked immunosorbent assay measurement of serum immunoglobulin G antibodies and proliferation assay of peripheral blood mononuclear cells, blood samples were obtained before and 1 month after immunization. Local and systemic reactions were recorded on diary cards for 15 days after immunization. RESULTS: After immunization with dTpa or pa, significant and comparable rises in geometric mean values of antibodies (12- to 46-fold) and proliferations (8- to 18-fold) to each of the pertussis antigens were noted. After immunization with dTpa or Td, significant rises in geometric mean values of antidiphtheria and antitetanus antibodies (35- to 76-fold) were noted, and all subjects had values of these antibodies >/=.1 international units/mL. The dTpa and pa vaccines were at least as well tolerated as the licensed Td vaccine. CONCLUSIONS: Booster immunization of adolescents with an acellular vaccine containing reduced quantities of pertussis antigens in addition to diphtheria and tetanus toxoids induces good responses in both arms of the immune system without an increase in adverse reactions.


Subject(s)
Antibodies, Bacterial/blood , Immunization, Secondary , Pertussis Vaccine/immunology , Adolescent , Antigens, Bacterial/immunology , Child , Diphtheria Toxoid/immunology , Diphtheria-Tetanus Vaccine , Diphtheria-Tetanus-Pertussis Vaccine/immunology , Diphtheria-Tetanus-acellular Pertussis Vaccines , Female , Humans , Immunization, Secondary/adverse effects , Male , Pertussis Vaccine/administration & dosage , Pertussis Vaccine/adverse effects , Single-Blind Method , Tetanus Toxoid/immunology , Vaccines, Combined/immunology , Whooping Cough/immunology
14.
Clin Diagn Lab Immunol ; 6(4): 534-6, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10391857

ABSTRACT

Five outbreaks of infection (three pertussis, one parapertussis, and one mixed) in schools were studied prospectively. Nasopharyngeal swabs were obtained from a total of 697 children for culture of Bordetella organisms. Of 50 vaccinated children with culture-confirmed Bordetella infections (29 with pertussis and 21 parapertussis), 40 were symptomatic and 10 remained symptom-free. Smaller numbers of colonies were recovered from the nasopharyngeal swabs of the asymptomatic children than from those of the symptomatic children. Older children had longer durations of illness than younger ones. Our results indicate that during outbreaks children who do not develop disease may have small amounts of Bordetella organisms in their nasopharynges and/or better immune defenses against the disease.


Subject(s)
Bordetella Infections/prevention & control , Vaccination , Adolescent , Age Factors , Child , Colony Count, Microbial , Disease Outbreaks/prevention & control , Female , Humans , Immunity , Male , Nasopharynx/microbiology , Respiratory System/immunology , Respiratory System/microbiology , Time Factors , Treatment Outcome
15.
Pediatr Infect Dis J ; 18(4): 366-70, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10223692

ABSTRACT

BACKGROUND: Increasing evidence suggests that cell-mediated immunity (CMI) is involved in immune response against Bordetella pertussis. However, there are practically no studies evaluating the significance of pertussis-specific CMI in relation to protection against clinical pertussis. METHODS: An outbreak of pertussis was studied prospectively in 13-year-old pupils in a rural school. B. pertussis infection was diagnosed by culture, microagglutination and enzyme immunoassay serology with the use of pertussis toxin, filamentous hemagglutinin and pertactin as antigens. Pertussis-specific CMI responses were assessed by in vitro proliferation assay of peripheral blood mononuclear cells. RESULTS: At the initial sampling 7 of 22 children had symptoms suggestive of pertussis and 15 were asymptomatic. Of the latter 3 remained healthy, 8 were later confirmed to have had asymptomatic infection, 3 developed laboratory-confirmed pertussis and 1 developed cough without laboratory evidence of pertussis. Initial in vitro proliferations of peripheral blood mononuclear cells induced by pertussis toxin, filamentous hemagglutinin and/or pertactin were positive in all 3 healthy children, in 6 of 8 children who had asymptomatic infection, but in none of the 3 children who later developed pertussis. Although some children who remained healthy had high values of antibodies, no clear association was found between initial serum antibody values and clinical outcome. CONCLUSIONS: These preliminary data suggest that CMI may have an important role in protection against clinical pertussis but do not exclude a role for antibodies. Furthermore the results stress a multifactorial nature of the immune protection against B. pertussis.


Subject(s)
Antibodies, Bacterial/analysis , Antigens, Bacterial/analysis , Bordetella pertussis/immunology , Whooping Cough/immunology , Adolescent , Bordetella pertussis/isolation & purification , Disease Outbreaks , Female , Humans , Immunity, Cellular , Longitudinal Studies , Male , Schools , Whooping Cough/diagnosis , Whooping Cough/epidemiology , Whooping Cough/prevention & control
16.
JAMA ; 280(7): 635-7, 1998 Aug 19.
Article in English | MEDLINE | ID: mdl-9718056

ABSTRACT

CONTEXT: The prevalence of Bordetella pertussis and Bordetella parapertussis infections among outpatients in an immunized population is not known. OBJECTIVE: To study the prevalence of these infections in outpatients with paroxysmal cough in Finland, where the pertussis vaccine coverage of 4 doses is 98%. DESIGN: Prospective cohort study. SETTING: Thirty-two health centers in southwestern Finland. PATIENTS: A total of 584 patients with paroxysmal cough seen at local health centers from October 1994 through March 1997 from whom nasopharyngeal swabs were collected. MAIN OUTCOME MEASURES: Prevalence of positive cultures for B pertussis or B parapertussis and/or positive polymerase chain reaction (PCR) results and frequency of symptoms in those with pertussis and parapertussis. RESULTS: A total of 153 subjects (26.2%) had Bordetella infection by culture or PCR: 93 (60.8%) had B pertussis infection, 49 (32.0%) had B parapertussis infection, and 1 1 (7.2%) had both. Of these cases, 39 (25.5%) had positive cultures and 95 (62.1%) had positive PCR results for B pertussis, and 19 (12.4%) had positive cultures and 55 (35.9%) had positive PCR results for B parapertussis. At the time of diagnosis, no difference was found in the frequency of symptoms between patients with B parapertussis infection and those with B pertussis infection. Bordetella parapertussis infection was as common as B pertussis infection in children before school entry, whereas in schoolchildren and adults, B pertussis infection was more common than B parapertussis infection (P<.001). CONCLUSION: Bordetella infections are common in an immunized population, and B parapertussis infections apparently are more prevalent than previously documented.


Subject(s)
Pertussis Vaccine , Whooping Cough/epidemiology , Whooping Cough/prevention & control , Adolescent , Adult , Aged , Bordetella/isolation & purification , Bordetella Infections/diagnosis , Bordetella Infections/epidemiology , Bordetella Infections/prevention & control , Bordetella pertussis/isolation & purification , Child , Child, Preschool , DNA, Bacterial/analysis , Female , Finland/epidemiology , Humans , Infant , Male , Middle Aged , Pertussis Vaccine/immunology , Polymerase Chain Reaction , Prevalence , Prospective Studies , Whooping Cough/diagnosis
17.
Vaccine ; 16(17): 1604-10, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9713935

ABSTRACT

235 healthy 10-12 years old school children were randomly immunized with either a booster dose of diphtheria-tetanus-acellular pertussis (dTap) or diphtheria-tetanus (dT) vaccine. For this booster immunization designed for school children and adults, the quantities of Bordetella pertussis antigens in the dTap vaccine had been reduced to one third of those of the Infanrix vaccine (SmithKline Beecham) commonly used for infants. IgG antibodies and cell-mediated immune (CMI) responses to pertussis toxin (PT), pertactin (PRN) and filamentous hemagglutinin (FHA) were assessed by an enzyme immunosorbent assay and in vitro proliferation of peripheral blood mononuclear cells, respectively. Before immunization, 55%, 80% and 99% of children had detectable serum IgG antibodies to PT, PRN and FHA, whereas CMI response was found in 35%, 27% and 50% of children, respectively. After immunization, a 20-30-fold increase in geometric mean level (GML) of antibodies to the pertussis antigens occurred and CMI response to PT, PRN and FHA was seen in 88%, 94% and 100% of children, respectively. Adverse reactions following the immunization were rare. The results show that booster immunization with an acellular pertussis vaccine with reduced concentrations of antigens induces both antibody and CMI responses and support further studies of this pertussis vaccine in school children.


Subject(s)
Antibodies, Bacterial/blood , Bordetella pertussis/immunology , Immunization, Secondary , Lymphocyte Activation , Pertussis Vaccine/immunology , Child , Female , Humans , Male
18.
Infect Immun ; 66(8): 3796-801, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9673264

ABSTRACT

Pertussis infection is increasingly recognized in older children and adults, indicating the need of booster immunizations in these age groups. We investigated the induction of pertussis-specific immunity in schoolchildren and adults after booster immunization and natural infection. The expression of mRNA of gamma interferon (IFN-gamma), interleukin-2 (IL-2), IL-4, and IL-5 in the peripheral blood mononuclear cells (PBMCs) was assayed by reverse transcription-PCR. The PBMCs of 17 children immunized with one dose of an acellular vaccine containing pertussis toxin (PT), filamentous hemagglutinin (FHA), and pertactin (PRN) significantly proliferated in vitro after stimulation with the vaccine antigens. The PBMCs of seven infected individuals markedly proliferated in the presence of PT and FHA, but the cells of only two of these subjects responded to PRN. At least one of the antigens induced mRNA for IL-4 and/or IL-5 in the cells of 93% of tested vaccinees and patients, and FHA induced IFN-gamma mRNA in the cells of two-thirds of them. Expression of mRNA for IFN-gamma correlated with the production of the cytokine protein. Anti-FHA immunoglobulin G antibodies significantly correlated with FHA-induced proliferative responses both before and after immunization. These results show that booster immunization with acellular pertussis vaccine induces both antibody- and cell-mediated immune responses in schoolchildren. Further, booster immunization and natural infection seem to induce the expression of mRNA of T-helper 1 (Th1) and Th2 type cytokines in similar manners. This observation supports the use of acellular pertussis vaccines for booster immunizations of older children, adolescents, and adults.


Subject(s)
Adhesins, Bacterial/immunology , Antigens, Bacterial/immunology , Bacterial Outer Membrane Proteins/immunology , Bordetella pertussis/immunology , Cytokines/biosynthesis , Hemagglutinins/immunology , Pertussis Toxin , Virulence Factors, Bordetella/immunology , Adult , Antibodies, Bacterial/immunology , Cell Division , Cells, Cultured , Child , Cytokines/genetics , Female , Gene Expression , Humans , Interferon-gamma/biosynthesis , Interferon-gamma/genetics , Interleukin-2/genetics , Interleukin-4/genetics , Interleukin-5/biosynthesis , Interleukin-5/genetics , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/metabolism , Male , Middle Aged , RNA, Messenger
19.
Scand J Immunol ; 45(2): 203-12, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9042433

ABSTRACT

In the present study the phenotype and function of lymphocytes from patients with common variable immunodeficiency (CVI) were studied. Five out of 12 patients had abnormally low proportion of CD4+ T cells, but PBMC of these patients were capable of proliferating in response to polyclonal T-cell mitogens or PPD antigen. The phenotype of patients' B cells, as determined by expression of CD10, CD19 and CD34, was comparable to that of healthy controls. IL-4 and anti-CD40 MoAbs induced moderate B-cell differentiation in PBMC derived from patients with CVI, but the frequencies of Ig-secreting cells were generally at levels spontaneously observed in healthy controls. IL-10 was completely ineffective in inducing IgG-secreting cells in cultures of PBMC derived from patients with CVI even in the presence of anti-CD40 MoAbs, whereas high frequencies of Ig-secreting cells were induced under similar condition in cultures of PBMC derived from healthy controls. Importantly, when IL-4 was added to cultures stimulated with anti-CD40 MoAbs and IL-10, a very strong synergistic effect on the numbers of Ig-secreting cells and the levels of Ig secretion was observed in PBMC from both patients and controls. Moreover, the frequencies of Ig-secreting cells after activation with anti-CD40 MoAbs, IL-4 plus IL-10 in PBMC from some patients were comparable to those observed in PBMC from healthy controls. Taken together, these results indicate that B cells from patients with CVI have impaired capacity to differentiate into Ig-secreting cells in response to IL-10 and anti-CD40 MoAbs, and that this unresponsiveness can be restored by exogenous IL-4 in a proportion of the patients.


Subject(s)
Antibodies, Monoclonal/pharmacology , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , CD40 Antigens/immunology , Common Variable Immunodeficiency/immunology , Interleukin-10/pharmacology , Interleukin-4/pharmacology , Leukocytes, Mononuclear/drug effects , Lymphocyte Activation , Adolescent , Adult , Aged , Antigens, CD19/analysis , Antigens, CD19/immunology , Antigens, CD34/analysis , Antigens, CD34/immunology , Bacterial Proteins/pharmacology , CD3 Complex/analysis , CD3 Complex/immunology , CD4 Lymphocyte Count , CD4-CD8 Ratio , CD8 Antigens/analysis , CD8 Antigens/immunology , Cells, Cultured , Child , Concanavalin A/pharmacology , Drug Synergism , Female , Flow Cytometry , HLA-DR Antigens/analysis , HLA-DR Antigens/immunology , Humans , Immunoglobulins/metabolism , Interleukin-13/pharmacology , Interleukin-2/pharmacology , Leukocyte Common Antigens/analysis , Leukocyte Common Antigens/immunology , Male , Middle Aged , Phytohemagglutinins/pharmacology , Pokeweed Mitogens/pharmacology , Receptors, Interleukin-2/analysis , Receptors, Interleukin-2/immunology , Recombinant Proteins/pharmacology , Tuberculin/pharmacology
20.
J Immunol ; 158(2): 574-9, 1997 Jan 15.
Article in English | MEDLINE | ID: mdl-8992970

ABSTRACT

Specific Ab-secreting cells (ASC) appear in the human blood as a response to oral and parenteral vaccination. The actual contribution of these cells to the defense of the body depends on their final effector site. The homing potentials of mucosally and parenterally induced ASC were compared by examining the homing receptor (HR) expression of circulating specific ASC in the blood of volunteers vaccinated orally or parenterally with the same Ag, Salmonella typhi Ty21a. Circulating lymphocytes were separated into receptor-positive and -negative populations, and the numbers of specific ASC were assayed. The alpha4 beta7 integrin, which acts as a gut HR, was expressed on all (99%) of the mucosally activated ASC, but on only 58% of the parenterally induced ASC or 58% of all Ig-secreting cells of the unvaccinated controls. L-selectin, the peripheral lymph node HR, showed an inverse distribution; it was found on 42% of mucosally activated ASC and on 86% of parenterally induced ASC. These results reveal that all of the circulating ASC after oral vaccination are committed to migrate to the mucosal compartment of the immune system, strongly arguing for a recirculation of activated mucosal cells in humans. By contrast, ASC induced by parenteral vaccination with the same Ag are mostly directed to the systemic compartment, yet a part of them has mucosal homing attitudes as well. These differences indicate that the site of Ag encounter determines the homing potential of the cell.


Subject(s)
Antibody-Producing Cells/immunology , Intestines/immunology , Receptors, Lymphocyte Homing/immunology , Typhoid-Paratyphoid Vaccines/administration & dosage , Typhoid-Paratyphoid Vaccines/immunology , Administration, Oral , Adult , CD28 Antigens/biosynthesis , Female , HLA-DR Antigens/biosynthesis , Humans , Immunoglobulin Isotypes/immunology , Injections, Intramuscular , Integrins/biosynthesis , Integrins/immunology , L-Selectin/biosynthesis , Lymphocyte Activation/immunology , Male , Middle Aged , Organ Specificity/immunology , Salmonella typhi/immunology , Vaccination/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...